IART Q4 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$383M+4.0% YoY

Gross Profit

$237M61.8% margin

Operating Income

$34M8.9% margin

Net Income

$25M6.6% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$43M

Free Cash Flow

$17M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$1.7B

Stockholders' Equity

$1.4B

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$383M	$369M	+4.0%
Gross Profit	$237M	$220M	+7.4%
Operating Income	$34M	$7M	+372.5%
Net Income	$25M	$44M	-43.3%

Revenue Segments

Codman Specialty Surgical

$249M65%

Orthopedics and Tissue Technologies

$134M35%

Geographic Segments

UNITED STATES

$276M72%

Europe

$51M13%

Asia Pacific

$36M9%

Rest Of World

$20M5%